Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 716 (USA) (Dr. Ito)
· consented 2013-12-16
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild CHEST PAIN — outcome: RECOVERED/RESOLVED; onset 2014-04-05 (study day 111.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild ELECTROCARDIOGRAM T WAVE INVERSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-14 (study day 89.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-14 (study day 30.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild HYPERHIDROSIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-01 (study day 17.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-14 (study day 30.0); relationship: PROBABLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.